Futura Medical shares surge after "transformational year"
6th Feb 2024 12:24
(Alliance News) - Futura Medical PLC on Tuesday reported its first revenues in 2023, thanks to the successful global roll-out of Eroxon. Read More
(Alliance News) - Futura Medical PLC on Tuesday reported its first revenues in 2023, thanks to the successful global roll-out of Eroxon. Read More
(Alliance News) - Futura Medical PLC on Monday said that it has extended its exclusive licensing agreement with Cooper Consumer Health Group, a European self-care organisation, to January 2029. Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - Futura Medical PLC on Wednesday said the Mexican Secretariat of Health has granted over the counter sale marketing authorisation for its erectile dysfunction topical gel formulation Eroxon. Read More
Futura Medical PLC - Guildford, Surrey-based pharmaceutical company - Says that it has launched Exoron in the United Arab Emirates. Exoron, or MED3000, is a topical gel used to treat erectile dysfunction. It uses Futura's proprietary technology, DermaSys. The product is now available for purchase online through the BinSina Pharmacy in the UAE, the first market in the Middle East to stock the product. Read More
Futura Medical PLC - Guildford, Surrey-based pharmaceutical company - Receives European patent for erectile dysfunction treatment, MED3000, until 2040. Continues to pursue patent applications to provide wider patent protection. Chief Executive Officer James Barder says: "The allowance of this patent application further cements the intellectual property of MED3000, as we support our distributors' roll out of our fast acting topically applied gel for the treatment of erectile dysfunction available without a doctor's prescription across the world." Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
Futura Medical PLC - Surrey, England-based pharmaceutical company - Says its distribution partner, Labatec Pharma, received regulatory approval for MED3000 in Saudi Arabia. MED3000 is Futura's topical, gel-based erectile dysfunction treatment. Labatec will exclusively launch and commercialise MED3000 under the brand name Eroxon, with initial launch planned in the final quarter of 2023. Adds the manufacturing of Eroxon for launch has been completed. Read More
(Alliance News) - Futura Medical PLC on Tuesday said it appointed Non-Executive Chair Jeff Needham as the successor to outgoing chair John Clarke, who has stepped down. Read More
(Alliance News) - Futura Medical PLC on Monday said it agreed a licensing deal with Haleon PLC for the rights to exclusively commercialise Futura's erectile dysfunction treatment Med3000 in the US. Read More
Futura Medical PLC - Guildford, Surrey-based pharmaceutical company - Says it is encouraged by the early growth trajectory of erectile dysfunction treatment gel Eroxon following its recent launch. "Both initial orders of Eroxon by our partners and in-market demand have been in line with our expectations and should continue to build as partners expand sales channels, numbers of outlets and new geographies," it adds. Predicts that net revenue for the six months ending June 30 will be no less than GBP1.5 million. Says momentum continues to build as it enters the commercialisation phase and positions itself to receive its first significant revenue in 2023. It previously in April said that its 2022 pretax loss widened to GBP6.9 million from GBP5.8 million the year before. Read More
<div class="kv-propertyview-value view-field en kv-propertiesview-container"><table style="width: 653px;" border="0" cellspacing="0" cellpadding="0"><colgroup><col width="205" /> <col width="448" /> </colgroup><tbody><tr><td class="xl67" width="205" height="20"><strong>Friday 16 June</strong></td><td width="448"> </td></tr><tr><td height="20">Alpha Growth PLC</td><td>AGM</td></tr><tr><td height="20">Anglo-Eastern Plantations PLC</td><td>AGM</td></tr><tr><td height="20">Gulf Keystone Petroleum Ltd</td><td>AGM</td></tr><tr><td height="20">John Lewis of Hungerford PLC</td><td>GM re proposed cancellation of admission to trading on AIM</td></tr><tr><td height="20">Tesco PLC</td><td>AGM</td></tr><tr><td height="20">Woodbois Ltd</td><td>AGM</td></tr><tr><td class="xl66" height="20"><strong>Monday 19 June</strong></td><td> </td></tr><tr><td class="xl68" height="20">All ThingsConsidered Group PLC</td><td>AGM</td></tr><tr><td height="20">Blackbird PLC</td><td>AGM</td></tr><tr><td height="20">Finsbury Food Group PLC</td><td>AGM</td></tr><tr><td height="20">Globalworth Real Estate Investments Ltd</td><td>AGM</td></tr><tr><td height="20">Marlowe PLC</td><td>GM re proposed capital reduction</td></tr><tr><td height="20">Metals Exploration PLC</td><td>AGM</td></tr><tr><td height="20">Red Rock Resources PLC</td><td>GM re security conversion into shares for cash</td></tr><tr><td height="20">Savannah Resources PLC</td><td>AGM</td></tr><tr><td class="xl66" height="20"><strong>Tuesday 20 June</strong></td><td> </td></tr><tr><td height="20">Acceler8 Ventures PLC</td><td>AGM</td></tr><tr><td height="20">Afentra PLC</td><td>AGM</td></tr><tr><td height="20">Armadale Capital PLC</td><td>AGM</td></tr><tr><td height="20">Bay Capital PLC</td><td>AGM</td></tr><tr><td height="20">Blackrock Smaller Companies Trust PLC</td><td class="xl68">AGM</td></tr><tr><td height="20">Block Energy PLC</td><td>AGM</td></tr><tr><td height="20">Corero Network Security PLC</td><td>AGM</td></tr><tr><td height="20">Coro Energy PLC</td><td>AGM</td></tr><tr><td height="20">Crimson Tide PLC</td><td>AGM</td></tr><tr><td height="20">Curtis Banks Group PLC</td><td>AGM</td></tr><tr><td height="20">EPE Special Opportunities Ltd</td><td>AGM</td></tr><tr><td height="20">ICG-Longbow Senior Secured UK Property Debt Investments Ltd</td><td>AGM</td></tr><tr><td height="20">Jersey Oil & Gas PLC</td><td>AGM</td></tr><tr><td height="20">Kore Potash PLC</td><td>AGM</td></tr><tr><td height="20">Lords Group Trading PLC</td><td>AGM</td></tr><tr><td height="20">Mission Group PLC</td><td>AGM</td></tr><tr><td height="20">North Atlantic Smaller Cos Investment Trust PLC</td><td>AGM</td></tr><tr><td height="20">Red Capital PLC</td><td>AGM</td></tr><tr><td height="20">Saga PLC</td><td>AGM</td></tr><tr><td height="20">SDX Energy PLC</td><td>AGM</td></tr><tr><td height="20">Skillcast Group PLC</td><td>AGM</td></tr><tr><td height="20">Zegona Communications PLC</td><td>AGM</td></tr><tr><td class="xl66" height="20"><strong>Wednesday 21 June</strong></td><td> </td></tr><tr><td height="20">Argentex Group PLC</td><td>AGM</td></tr><tr><td height="20">Clean Power Hydrogen PLC</td><td>AGM</td></tr><tr><td height="20">Eqtec PLC</td><td>AGM</td></tr><tr><td height="20">Hydrogen Utopia International PLC</td><td>AGM</td></tr><tr><td class="xl68" height="20">HSS Hire Group PLC</td><td class="xl68">AGM</td></tr><tr><td height="20">Intelligent Ultrasound Group PLC</td><td>AGM</td></tr><tr><td height="20">JD.com Inc</td><td>AGM</td></tr><tr><td height="20">RTW Venture Fund Ltd</td><td>AGM</td></tr><tr><td height="20">Schroders Capital Global Innovation Trust PLC</td><td>AGM</td></tr><tr><td height="20">Sivota PLC</td><td>AGM</td></tr><tr><td height="20">Numis Corp PLC</td><td class="xl68">GM re acquisition by Deuche Bank AG</td></tr><tr><td height="20">THG PLC</td><td>AGM</td></tr><tr><td height="20">UK Commercial Property REIT Ltd</td><td>AGM</td></tr><tr><td class="xl67" width="205" height="20"><strong>Thursday 22 June</strong></td><td> </td></tr><tr><td height="20">Alphawave IP Group PLC</td><td>AGM</td></tr><tr><td height="20">Angling Direct PLC</td><td>AGM</td></tr><tr><td height="20">Anglo Asian Mining PLC</td><td>AGM</td></tr><tr><td height="20">boohoo Group PLC</td><td>AGM</td></tr><tr><td height="20">Card Factory PLC</td><td>AGM</td></tr><tr><td height="20">Ergomed PLC</td><td>AGM</td></tr><tr><td height="20">Futura Medical PLC</td><td>AGM</td></tr><tr><td height="20">Good Energy Group PLC</td><td>AGM</td></tr><tr><td height="20">Grand Vision Media Holdings PLC</td><td>AGM</td></tr><tr><td height="20">Longboat Energy PLC</td><td>AGM</td></tr><tr><td height="20">MaxRets Ventures PLC</td><td>AGM</td></tr><tr><td height="20">Pathfinder Minerals PLC</td><td>AGM</td></tr><tr><td height="20">RBG Holdings PLC</td><td>AGM</td></tr><tr><td height="20">Sanderson Design Group PLC</td><td>AGM</td></tr><tr><td height="20">Team17 Group PLC</td><td>AGM</td></tr><tr><td height="20">Trellus Health PLC</td><td>AGM</td></tr><tr><td height="20">Whitbread PLC</td><td>AGM</td></tr></tbody></table><p> Read More
(Alliance News) - Stock prices in London were tentatively higher at midday on Monday, as investors looked ahead to a key US inflation print on Tuesday with some caution ahead of the Federal Reserve's next interest rate decision. Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday. Read More
(Alliance News) - Futura Medical PLC said on Monday that the US Food & Drug Administration granted over the counter sale marketing authorising for MED3000, the company's treatment of erectile dysfunction. Read More
(Alliance News) - Futura Medical PLC announced on Tuesday that its erectile dysfunction treatment gel Eroxon is now available for purchase in the UK. Read More
(Alliance News) - Futura Medical PLC said on Wednesday its annual loss widened as it focused on the commercialisation of its new MED3000 product. Read More
Futura Medical PLC - Surrey, England-based sexual health-focused pharmaceutical company - Says it has submitted a full response to questions from the US Food & Drug Administration and confirmatory data regarding its MED3000 erectile dysfunction treatment. This is for the FDA to continue its review of the product. Notes that it expects the grant of the De Novo request in the second quarter of 2023. A De Novo classification by the FDA provides an alternate pathway to marketing approval for novel medical devices. Read More